Pharmaceutical Consulting Serv is categorized under Industry Specialist Consultants in Baton Rouge, LA and active since 2001.
Pharmaceutical Consulting Serv was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Industry Specialist Consultants business, which does work in the B2B market, and is classified as a Industry Specialist Consultants, under code number 541611 by the NAICS.
If you are seeking more information, feel free to contact Otto Olson at the company’s single location by writing to 712 Woodleigh Drive, Baton Rouge, Louisiana LA 70810 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pharmaceutical Consulting Serv |
| Contact Person: | Otto Olson |
| Address: | 712 Woodleigh Drive, Baton Rouge, Louisiana 70810 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Industry Specialist Consultants |
| SIC Code: | 8742 |
| NAICS Code: | 541611 |
| Share This Business: |
Pharmaceutical Consulting Serv was started in 2001 to provide professional Industry Specialist Consultants under the SIC code 8742 and NAICS code 541611. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Otto Olson for inquiries that concern Pharmaceutical Consulting Serv by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Pharmaceutical Consulting Serv can be found at the coordinates as well as the street address 712 Woodleigh Drive in Baton Rouge, Louisiana 70810.
For its online presence, you may visit Pharmaceutical Consulting Serv’s website at and engage with its social media outlets through on Twitter and on Facebook.